Thomas A. Raffin - Jun 1, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Director
Signature: /s/ Thomas A. Raffin, by Brian McKelligon, as Attorney-in-Fact
Stock symbol: AKYA
Transactions as of: Jun 1, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/3/2022, 04:04 PM
Previous filing: May 9, 2022
Next filing: Aug 26, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AKYA	Common Stock						215K	Jun 1, 2022	Thomas A. Raffin Living Trust dated March 29, 2017	F1
holding	AKYA	Common Stock						14.1M	Jun 1, 2022	See Footnote	F2
holding	AKYA	Common Stock						1.54M	Jun 1, 2022	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AKYA	Stock Option (Right to Buy	Award	$0	+30.5K		$0.00	30.5K	Jun 1, 2022	Common Stock	30.5K	$11.24	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Since the date of the reporting person's last ownership report, he transferred 213,592 shares of common stock to his ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his exspouse. In addition, 214,092 shares were transferred to the Thomas A. Raffin Living Trust dated March 29, 2017, of which Thomas A. Raffin serves as Trustee.
F2	Shares held directly by Telegraph Hill Partners III, L.P. ("THP III"). Telegraph Hill Partners III Investment Management, LLC ("THP IM") is the general partner of THP III. Telegraph Hill Partners Management Company, LLC ("THPMC") is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3	Shares held directly by THP III Affiliates Fund, LLC ("THP III AFF"). THP IM is the manager of THP III AFF. THPMC is the manager of THP IM. J. Matthew Mackowski, Dr. Thomas A. Raffin and Deval Lashkari are each managers of THPMC and may be deemed to share voting and dispositive power over the securities held by THP III Affiliates. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F4	Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.